Exercise and Diet Intervention Attenuated Inflammation Through ASC Gene and Inflammatory Markers in Obese Adults (INDIEX)
Primary Purpose
Inflammatory Response, Obesity, Abdominal Obesity
Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Exercise-Diet Intervention
Diet Intervention
Sponsored by
About this trial
This is an interventional treatment trial for Inflammatory Response focused on measuring Nutrition, Exercise, Diet, Inflammation, Obesity
Eligibility Criteria
Inclusion Criteria:
- BMI greater than 30 kg/m^2
- Sedentary individuals
- Both genres
- Waist circumference greater than 80 centimeters in women and greater than 90 centimeters in men
Exclusion Criteria:
- Pregnant or breastfeeding women
- Diagnosis of any metabolic disease or cancer
- Alcohol or tobacco consumption
- Muscle or joint injury
Sites / Locations
- Erika Martínez-López
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Exercise-Diet Group
Diet Group
Arm Description
The participants receive a personal exercise program according to Astrand-rhyming test baseline results, and a hypo-caloric diet intervention
The participants no receive a personal exercise program, only the hypo-caloric diet
Outcomes
Primary Outcome Measures
Change in ASC mRNA Expression
The polymorphonuclear cells were separated using Dextran treatment from peripheral blood samples. Subsequently, TRIzol® reagent was using according to the manufacturer´s instructions. The complementary DNA (cDNA) synthesis was performed according to standard techniques.
Quantitative real-time PCR was performed using TaqMan® probes in Light Cycler 96 equipment considering standards PCR conditions to analyze ASC mRNA relative expression by 2-ΔΔcq method. The amplification reactions were performed in duplicate using β-Actin gene as constitutive gene to normalized the samples.
Change in Pro-inflammatory and Anti-inflammatory Cytokines
The pro-inflammatory and anti-inflammatory cytokines quantification were using Bio-Plex Pro™ Human cytokine Standard 17-Plex, Group I kit following the supplier's instructions, and the read was immediately by MAGPIX™ analyzer.
Change in Astrand-rhyming Submaximal Test
The Astrand-rhyming submaximal test was performed as described by Astrand.
Secondary Outcome Measures
Changes in Height
Height in meters using a stadiometer.
Changes in Weight
The weight was measured in kilograms on InBody 370.
Changes in Body Mass Index (BMI)
Weight and height were be combined to report BMI in kg/m^2
Changes in Waist Circumference
Waist circumference was measured at the narrowest point between the edge of the inner rib and the iliac crest, with the participant in an abducted and relaxed position, after expiration using a Lufkin Executive® tape.
Changes in Fat Mass
The Fat Mass was measured in kilograms by electrical bioimpedance on InBody 370.
Changes in Musculoskeletal Mass
The musculoskeletal mass was measured in kilograms by electrical bioimpedance on InBody 370.
Changes in Serum Glucose
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Changes in Serum Insulin
Were determined through Insulin Model ELISA kit following the supplier's instructions.
Changes in homeostatic model assessment - insulin resistance (HOMA-IR)
Serum glucose and Insulin levels were be combined to report HOMA-IR calculated as described by Matthews.
Changes in Total Cholesterol
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Changes in High-density lipoprotein (c-HDL)
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Changes in Atherogenic Index
Serum total cholesterol and c-HDL were be combined to report atherogenic index, calculated through formula [Total cholesterol (mg/dL) / HDL-c (mg/dL)].
Full Information
NCT ID
NCT04315376
First Posted
March 15, 2020
Last Updated
March 17, 2020
Sponsor
University of Guadalajara
1. Study Identification
Unique Protocol Identification Number
NCT04315376
Brief Title
Exercise and Diet Intervention Attenuated Inflammation Through ASC Gene and Inflammatory Markers in Obese Adults
Acronym
INDIEX
Official Title
Exercise Program and Diet Intervention Attenuated Inflammation Through Down-regulation of ASC Gene and Inflammatory Markers in Obese Adults
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
February 10, 2018 (Actual)
Primary Completion Date
February 15, 2019 (Actual)
Study Completion Date
February 15, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Guadalajara
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Background: Obesity is one of the most important health problems worldwide, several factors related to lifestyle as physical inactivity and unbalanced diets increase their development. This condition is characterized by low-chronic inflammation by excess of adipose tissue. The apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) protein is part of NLRP3 inflammasome, a complex related to inflammation and metabolic alterations.
Purpose: The aim of this study was to evaluate the effect of physical exercise program on ASC gene expression and inflammatory markers in obese adults.
Methods: 37 obese individuals were randomized to exercise-diet group or diet-group during a 4-month follow-up period. The dietary evaluation was analyzed by Nutritionist Pro software. Body composition was evaluated by bioimpedance (InBody 370). All biochemical determinations were analyzed by dry chemistry (Vitros 350). ASC messenger ribonucleic acid (mRNA) expression was performed by real-time polymerase chain reaction (PCR) using Taqman probes and by the 2-ΔΔcq quantification method. Cytokine levels was performed using the Bio-PlexPro™ HumanTh17Cytokine Assays (MagPix) panel. Statistical analysis was performed with Statistical Package for the Social Sciences (SPSS) v.22 software.
Detailed Description
A randomized clinical trial was conducted in the Institute of Translational Nutrigenetics and Nutrigenomics, Department of Molecular Biology in Medicine, Health Sciences Center, at the University of Guadalajara, Guadalajara, Jalisco, Mexico, from February of 2018 to February of 2019. All participants were recruited through flyers and social media invitations. Sample size was determined according to the mean difference formula for clinical trials. To achieve a statistical power of 80% and an alpha of 5%, a sample size of 13 participants in each study group was required. However, 37 obese individuals who met the selection criteria were randomized in exercise-diet group or diet-group. Blood sample, height and weight were measured after 8-12 hour fast and wearing light clothes. The participants in the exercise-diet group were cited in the Respiratory Unit of the University of Guadalajara with the indication of not consuming caffeine, tobacco or energy drinks 24 hours before the test, and not having eaten food at least two hours before the Astrand-rhyming Test. This study was approved by the Ethics and Biosafety Committee of the Health Sciences Center, University of Guadalajara (registry number CUCS/CINV/0476/18). The procedures were in accordance with this institution's guidelines and all the participants signed a written consent-informed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammatory Response, Obesity, Abdominal Obesity, Diet Habit, Exercise
Keywords
Nutrition, Exercise, Diet, Inflammation, Obesity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
37 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Exercise-Diet Group
Arm Type
Experimental
Arm Description
The participants receive a personal exercise program according to Astrand-rhyming test baseline results, and a hypo-caloric diet intervention
Arm Title
Diet Group
Arm Type
Active Comparator
Arm Description
The participants no receive a personal exercise program, only the hypo-caloric diet
Intervention Type
Behavioral
Intervention Name(s)
Exercise-Diet Intervention
Intervention Description
The participants who performed exercise-diet intervention performed an Astrand-rhyming test before and after the exercise program intervention. Participants followed a progressive exercise-program during four months according to initial physical fitness. The main exercises consisted of improving aerobic, speed and resistance performance. During all single sessions, breathlessness and fatigue were measured using 0 to10 Borg scale. A personal trainer certified by American College of Sports Medicine (ACSM) supervised three sessions per week, the other two unsupervised training days the subjects were given the detailed training program to do in house/park. And also, this group received a diet intervention that consisted of a 20 percentage reduction of total energy expenditure estimated by the Mifflin formula with a nutrients distribution as follows: 50% carbohydrates, 30% lipids, and 20% proteins.
Intervention Type
Behavioral
Intervention Name(s)
Diet Intervention
Intervention Description
This group received a diet intervention that consisted of a 20 percentage reduction of total energy expenditure estimated by the Mifflin formula with a nutrients distribution as follows: 50% carbohydrates, 30% lipids, and 20% proteins.
Primary Outcome Measure Information:
Title
Change in ASC mRNA Expression
Description
The polymorphonuclear cells were separated using Dextran treatment from peripheral blood samples. Subsequently, TRIzol® reagent was using according to the manufacturer´s instructions. The complementary DNA (cDNA) synthesis was performed according to standard techniques.
Quantitative real-time PCR was performed using TaqMan® probes in Light Cycler 96 equipment considering standards PCR conditions to analyze ASC mRNA relative expression by 2-ΔΔcq method. The amplification reactions were performed in duplicate using β-Actin gene as constitutive gene to normalized the samples.
Time Frame
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Title
Change in Pro-inflammatory and Anti-inflammatory Cytokines
Description
The pro-inflammatory and anti-inflammatory cytokines quantification were using Bio-Plex Pro™ Human cytokine Standard 17-Plex, Group I kit following the supplier's instructions, and the read was immediately by MAGPIX™ analyzer.
Time Frame
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Title
Change in Astrand-rhyming Submaximal Test
Description
The Astrand-rhyming submaximal test was performed as described by Astrand.
Time Frame
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Secondary Outcome Measure Information:
Title
Changes in Height
Description
Height in meters using a stadiometer.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month. 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Weight
Description
The weight was measured in kilograms on InBody 370.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Body Mass Index (BMI)
Description
Weight and height were be combined to report BMI in kg/m^2
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Waist Circumference
Description
Waist circumference was measured at the narrowest point between the edge of the inner rib and the iliac crest, with the participant in an abducted and relaxed position, after expiration using a Lufkin Executive® tape.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Fat Mass
Description
The Fat Mass was measured in kilograms by electrical bioimpedance on InBody 370.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Musculoskeletal Mass
Description
The musculoskeletal mass was measured in kilograms by electrical bioimpedance on InBody 370.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Serum Glucose
Description
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Serum Insulin
Description
Were determined through Insulin Model ELISA kit following the supplier's instructions.
Time Frame
At the baseline (0 Month), 3th month and the 4th month.
Title
Changes in homeostatic model assessment - insulin resistance (HOMA-IR)
Description
Serum glucose and Insulin levels were be combined to report HOMA-IR calculated as described by Matthews.
Time Frame
At the baseline (0 Month), 3th month and the 4th month.
Title
Changes in Total Cholesterol
Description
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in High-density lipoprotein (c-HDL)
Description
It was measured in mg/dL using a dry chemistry system in Vitros 350 equipment.
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Title
Changes in Atherogenic Index
Description
Serum total cholesterol and c-HDL were be combined to report atherogenic index, calculated through formula [Total cholesterol (mg/dL) / HDL-c (mg/dL)].
Time Frame
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI greater than 30 kg/m^2
Sedentary individuals
Both genres
Waist circumference greater than 80 centimeters in women and greater than 90 centimeters in men
Exclusion Criteria:
Pregnant or breastfeeding women
Diagnosis of any metabolic disease or cancer
Alcohol or tobacco consumption
Muscle or joint injury
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erika Martínez-López, PhD
Organizational Affiliation
University of Guadalajara
Official's Role
Principal Investigator
Facility Information:
Facility Name
Erika Martínez-López
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44340
Country
Mexico
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The individual participant data will not be shared to protect and safeguard the confidentiality data of the participants.
Citations:
PubMed Identifier
13211501
Citation
ASTRAND PO, RYHMING I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954 Sep;7(2):218-21. doi: 10.1152/jappl.1954.7.2.218. No abstract available.
Results Reference
result
PubMed Identifier
25488565
Citation
Lin CH, Chiang SL, Tzeng WC, Chiang LC. Systematic review of impact of lifestyle-modification programs on metabolic risks and patient-reported outcomes in adults with metabolic syndrome. Worldviews Evid Based Nurs. 2014 Dec;11(6):361-8. doi: 10.1111/wvn.12069.
Results Reference
result
PubMed Identifier
25653548
Citation
Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015 Jan 16;8:15-27. doi: 10.2147/JIR.S51250. eCollection 2015.
Results Reference
result
PubMed Identifier
25732273
Citation
Ross R, Hudson R, Stotz PJ, Lam M. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Ann Intern Med. 2015 Mar 3;162(5):325-34. doi: 10.7326/M14-1189.
Results Reference
result
PubMed Identifier
17805543
Citation
Taniguchi S, Sagara J. Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC. Semin Immunopathol. 2007 Sep;29(3):231-8. doi: 10.1007/s00281-007-0082-3. Epub 2007 Sep 6.
Results Reference
result
PubMed Identifier
23494259
Citation
You T, Arsenis NC, Disanzo BL, Lamonte MJ. Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms. Sports Med. 2013 Apr;43(4):243-56. doi: 10.1007/s40279-013-0023-3.
Results Reference
result
PubMed Identifier
32854610
Citation
Barron-Cabrera E, Gonzalez-Becerra K, Rosales-Chavez G, Mora-Jimenez A, Hernandez-Canaveral I, Martinez-Lopez E. Low-grade chronic inflammation is attenuated by exercise training in obese adults through down-regulation of ASC gene in peripheral blood: a pilot study. Genes Nutr. 2020 Aug 27;15(1):15. doi: 10.1186/s12263-020-00674-0.
Results Reference
derived
Learn more about this trial
Exercise and Diet Intervention Attenuated Inflammation Through ASC Gene and Inflammatory Markers in Obese Adults
We'll reach out to this number within 24 hrs